These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 19656241)

  • 1. Crosstalk between the NF-kappaB activating IKK-complex and the CSN signalosome.
    Orel L; Neumeier H; Hochrainer K; Binder BR; Schmid JA
    J Cell Mol Med; 2010 Jun; 14(6B):1555-68. PubMed ID: 19656241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COP9 signalosome controls the Carma1-Bcl10-Malt1 complex upon T-cell stimulation.
    Welteke V; Eitelhuber A; Düwel M; Schweitzer K; Naumann M; Krappmann D
    EMBO Rep; 2009 Jun; 10(6):642-8. PubMed ID: 19444310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IKK-Mediated Regulation of the COP9 Signalosome via Phosphorylation of CSN5.
    Zhang J; Zhao R; Yu C; Bryant CLN; Wu K; Liu Z; Ding Y; Zhao Y; Xue B; Pan ZQ; Li C; Huang L; Fang L
    J Proteome Res; 2020 Mar; 19(3):1119-1130. PubMed ID: 31950832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial CSN5 impairs NF-κB activation and monocyte adhesion to endothelial cells and is highly expressed in human atherosclerotic lesions.
    Asare Y; Shagdarsuren E; Schmid JA; Tilstam PV; Grommes J; El Bounkari O; Schütz AK; Weber C; de Winther MP; Noels H; Bernhagen J
    Thromb Haemost; 2013 Jul; 110(1):141-52. PubMed ID: 23636414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p97/VCP promotes Cullin-RING-ubiquitin-ligase/proteasome-dependent degradation of IκBα and the preceding liberation of RelA from ubiquitinated IκBα.
    Schweitzer K; Pralow A; Naumann M
    J Cell Mol Med; 2016 Jan; 20(1):58-70. PubMed ID: 26463447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted inactivation of the COP9 signalosome impairs multiple stages of T cell development.
    Panattoni M; Sanvito F; Basso V; Doglioni C; Casorati G; Montini E; Bender JR; Mondino A; Pardi R
    J Exp Med; 2008 Feb; 205(2):465-77. PubMed ID: 18268034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and biochemical characterization of the Cop9 signalosome CSN5/CSN6 heterodimer.
    Birol M; Enchev RI; Padilla A; Stengel F; Aebersold R; Betzi S; Yang Y; Hoh F; Peter M; Dumas C; Echalier A
    PLoS One; 2014; 9(8):e105688. PubMed ID: 25144743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAB1/CSN5 and the COP9 signalosome. A complex situation.
    Chamovitz DA; Segal D
    EMBO Rep; 2001 Feb; 2(2):96-101. PubMed ID: 11258719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Kinase-Mediated Decision Between the Life and Death.
    Engin A
    Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex.
    Tomoda K; Kubota Y; Arata Y; Mori S; Maeda M; Tanaka T; Yoshida M; Yoneda-Kato N; Kato JY
    J Biol Chem; 2002 Jan; 277(3):2302-10. PubMed ID: 11704659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of COP9 signalosome subunits differentially affects the CSN complex and target protein stability.
    Peth A; Berndt C; Henke W; Dubiel W
    BMC Biochem; 2007 Dec; 8():27. PubMed ID: 18093314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression pattern of the JAB1/CSN5 gene during murine embryogenesis: colocalization with NEDD8.
    Carrabino S; Carminati E; Talarico D; Pardi R; Bianchi E
    Gene Expr Patterns; 2004 Jul; 4(4):423-31. PubMed ID: 15183309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of COP9 signalosome in cancer.
    Lee MH; Zhao R; Phan L; Yeung SC
    Cell Cycle; 2011 Sep; 10(18):3057-66. PubMed ID: 21876386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rig-G negatively regulates SCF-E3 ligase activities by disrupting the assembly of COP9 signalosome complex.
    Xu GP; Zhang ZL; Xiao S; Zhuang LK; Xia D; Zou QP; Jia PM; Tong JH
    Biochem Biophys Res Commun; 2013 Mar; 432(3):425-30. PubMed ID: 23415865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.
    Karin M; Ben-Neriah Y
    Annu Rev Immunol; 2000; 18():621-63. PubMed ID: 10837071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging roles of Jab1/CSN5 in cancer.
    Wang L; Zheng JN; Pei DS
    Med Oncol; 2016 Aug; 33(8):90. PubMed ID: 27412572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-linked intellectual disability gene CUL4B targets Jab1/CSN5 for degradation and regulates bone morphogenetic protein signaling.
    He F; Lu D; Jiang B; Wang Y; Liu Q; Liu Q; Shao C; Li X; Gong Y
    Biochim Biophys Acta; 2013 May; 1832(5):595-605. PubMed ID: 23357576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the human COP9 signalosome.
    Lingaraju GM; Bunker RD; Cavadini S; Hess D; Hassiepen U; Renatus M; Fischer ES; Thomä NH
    Nature; 2014 Aug; 512(7513):161-5. PubMed ID: 25043011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSN-associated USP48 confers stability to nuclear NF-κB/RelA by trimming K48-linked Ub-chains.
    Schweitzer K; Naumann M
    Biochim Biophys Acta; 2015 Feb; 1853(2):453-69. PubMed ID: 25486460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The COP9 signalosome.
    Wei N; Deng XW
    Annu Rev Cell Dev Biol; 2003; 19():261-86. PubMed ID: 14570571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.